Trial Profile
Effect of lenalidomide and its association with primary malignancies in Moffitt Cancer Center patients with Myelodysplastic Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions
- 03 Jul 2015 New trial record